QPS moves forward with global expansion in response to client demand 26-Sep-2019 By Melissa Fassbender The CRO has opened a new clinic in response to demand for early-stage research, specifically for Alzheimer’s Disease, and expanded its footprint in India to conduct studies ‘at favorable pricing with faster timelines,’ say company executives.
CRO Altasciences sees opportunity in fragmented early clinical development space 27-Jun-2017 By Melissa Fassbender Altasciences Company has been acquired by Audax Private Equity as it looks to expand in the fragmented early clinical development space.
Quintiles selects OmniComm for Phase I software 22-Apr-2014 By Zachary Brennan CRO Quintiles has signed a five-year agreement to use OmniComm Systems' technology for Phase I clinic automation.
NPIL and Lilly form 'risk and reward' sharing alliance NPIL and Lilly form 'risk and reward' sharing alliance 19-Feb-2008 By Kirsty Barnes Nicholas Piramal (NPIL) has signed an innovative drug development deal with Eli Lilly - the second such agreement in a year.
PharmaNet broadens its offerings to broaden horizons PharmaNet broadens its offerings to broaden horizons 22-Mar-2007 By Kirsty Barnes PharmaNet has entered into a partnership with Analytica in a bid to broaden the clinical development and commercialisation services it offers.